69 related articles for article (PubMed ID: 19624866)
1. Predicting the response of advanced cervical and ovarian tumors to therapy.
Harry VN; Gilbert FJ; Parkin DE
Obstet Gynecol Surv; 2009 Aug; 64(8):548-60. PubMed ID: 19624866
[TBL] [Abstract][Full Text] [Related]
2. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
[TBL] [Abstract][Full Text] [Related]
3. Biological predictors of cervical cancer response to radiation therapy.
Klopp AH; Eifel PJ
Semin Radiat Oncol; 2012 Apr; 22(2):143-50. PubMed ID: 22385921
[TBL] [Abstract][Full Text] [Related]
4. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
5. Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
Quon H; Brizel DM
Semin Radiat Oncol; 2012 Jul; 22(3):220-32. PubMed ID: 22687947
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation.
Liu Y; Bai R; Sun H; Liu H; Zhao X; Li Y
Clin Radiol; 2009 Nov; 64(11):1067-74. PubMed ID: 19822239
[TBL] [Abstract][Full Text] [Related]
7. Functional magnetic resonance imaging in cervical cancer: current evidence and future directions.
Kundu S; Chopra S; Verma A; Mahantshetty U; Engineer R; Shrivastava SK
J Cancer Res Ther; 2012; 8(1):11-8. PubMed ID: 22531506
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
10. Novel imaging techniques as response biomarkers in cervical cancer.
Harry VN
Gynecol Oncol; 2010 Feb; 116(2):253-61. PubMed ID: 20109726
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging applications in uterine cervical cancer.
Mezrich R
Magn Reson Imaging Clin N Am; 1994 May; 2(2):211-43. PubMed ID: 7489286
[TBL] [Abstract][Full Text] [Related]
12. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in ovarian cancer.
Friedlander ML
Semin Oncol; 1998 Jun; 25(3):305-14. PubMed ID: 9633842
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications.
Lee G
Cancer Biomark; 2009; 5(3):137-42. PubMed ID: 19407368
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated alterations in caspase-14 expression in epithelial malignancies.
Krajewska M; Kim H; Shin E; Kennedy S; Duffy MJ; Wong YF; Marr D; Mikolajczyk J; Shabaik A; Meinhold-Heerlein I; Huang X; Banares S; Hedayat H; Reed JC; Krajewski S
Clin Cancer Res; 2005 Aug; 11(15):5462-71. PubMed ID: 16061862
[TBL] [Abstract][Full Text] [Related]
16. The preoperative diagnosis of borderline ovarian tumors: a review of current literature.
Morotti M; Menada MV; Gillott DJ; Venturini PL; Ferrero S
Arch Gynecol Obstet; 2012 Apr; 285(4):1103-12. PubMed ID: 22210294
[TBL] [Abstract][Full Text] [Related]
17. Profiling studies in ovarian cancer: a review.
Fehrmann RS; Li XY; van der Zee AG; de Jong S; Te Meerman GJ; de Vries EG; Crijns AP
Oncologist; 2007 Aug; 12(8):960-6. PubMed ID: 17766655
[TBL] [Abstract][Full Text] [Related]
18. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diffusion-weighted imaging as a predictive marker for tumor response in patients undergoing chemoradiation for postoperative recurrences of cervical cancer.
Chopra S; Verma A; Kundu S; Engineer R; Medhi S; Mahantshetty U; Gupta S; Shrivastava SK
J Cancer Res Ther; 2012; 8(1):68-73. PubMed ID: 22531517
[TBL] [Abstract][Full Text] [Related]
20. Signal characteristics of tumors shown by high-resolution endorectal coil magnetic resonance imaging may predict outcome among patients with cervical carcinoma treated with irradiation. A preliminary study.
Corn BW; Schnall MD; Milestone B; King S; Hauck W; Solin LJ
Cancer; 1996 Dec; 78(12):2535-42. PubMed ID: 8952562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
